Evidence map›Paper›PMID 35326580›Full record

ReviewCancers2022

Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.

Lelio Guida, Vittorio Stumpo, Jacopo Bellomo, Christiaan Hendrik Bas van Niftrik, Martina Sebök, Moncef Berhouma, Andrea Bink, Michael Weller, Zsolt Kulcsar, Luca Regli and 1 more

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Multiparametric simultaneous hybridQuantitative imaging in medicine and surgery · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lelio GuidaDepartment of Neurosurgery, University Hospital Zurich, 8091 Zurich, Switzerland.
Vittorio StumpoDepartment of Neurosurgery, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-8175-0035
Jacopo BellomoDepartment of Neurosurgery, University Hospital Zurich, 8091 Zurich, Switzerland.
Christiaan Hendrik Bas van NiftrikDepartment of Neurosurgery, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0003-0930-8717
Martina SebökDepartment of Neurosurgery, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-7246-3421
Moncef BerhoumaDepartment of Neurosurgical Oncology and Vascular Neurosurgery, Pierre Wertheimer Neurological and Neurosurgical Hospital, Hospices Civils de Lyon, 69500 Lyon, France.
Andrea BinkClinical Neuroscience Center, University Hospital Zurich, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0002-2163-3400
Michael WellerClinical Neuroscience Center, University Hospital Zurich, University of Zurich, 8057 Zurich, Switzerland.
Zsolt KulcsarClinical Neuroscience Center, University Hospital Zurich, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0002-6805-5150
Luca RegliDepartment of Neurosurgery, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0003-4639-4474
Jorn FierstraDepartment of Neurosurgery, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0001-6220-0727

Funding

Swiss Cancer League KFS-3975-08-2016-R
6 · The paper itself

Abstract

Diffuse gliomas are the most common primary malignant intracranial neoplasms. Aside from the challenges pertaining to their treatment-glioblastomas, in particular, have a dismal prognosis and are currently incurable-their pre-operative assessment using standard neuroimaging has several drawbacks, including broad differentials diagnosis, imprecise characterization of tumor subtype and definition of its infiltration in the surrounding brain parenchyma for accurate resection planning. As the pathophysiological alterations of tumor tissue are tightly linked to an aberrant vascularization, advanced hemodynamic imaging, in addition to other innovative approaches, has attracted considerable interest as a means to improve diffuse glioma characterization. In the present part A of our two-review series, the fundamental concepts, techniques and parameters of hemodynamic imaging are discussed in conjunction with their potential role in the differential diagnosis and grading of diffuse gliomas. In particular, recent evidence on dynamic susceptibility contrast, dynamic contrast-enhanced and arterial spin labeling magnetic resonance imaging are reviewed together with perfusion-computed tomography. While these techniques have provided encouraging results in terms of their sensitivity and specificity, the limitations deriving from a lack of standardized acquisition and processing have prevented their widespread clinical adoption, with current efforts aimed at overcoming the existing barriers.

Indexed as

cerebral gliomacerebrovascular reactivityglioblastomahemodynamicMRIperfusion computed tomographyperfusion MRI

Identifiers

PMID35326580
PMCPMC8946242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.